Dow Up0.76% Nasdaq Up0.69%

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
1.83 Down 0.08(4.19%) Oct 24, 4:00PM EDT
|After Hours : 1.83 0.00 (0.00%) Oct 24, 4:52PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue -   -   5,750   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   5,750   -  
Operating Expenses
Research Development20,063  16,869  18,046  17,574  
Selling General and Administrative5,393  5,516  4,648  4,677  
Non Recurring -   -   -  1,679  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (25,456) (22,385) (16,944) (23,930)
Income from Continuing Operations
Total Other Income/Expenses Net65  82  83  106  
Earnings Before Interest And Taxes(25,391)(22,303)(16,861)(23,824)
Interest Expense -   -   -   -  
Income Before Tax(25,391)(22,303)(16,861)(23,824)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(25,391)(22,303)(16,861)(23,824)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (25,391) (22,303) (16,861) (23,824)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (25,391) (22,303) (16,861) (23,824)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.